A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Clinical trial NCT02661815 · TERMINATED

Trial details

NCT number: NCT02661815
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2016-06-15
Primary completion: 2017-06-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.